Status:
UNKNOWN
Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD
Lead Sponsor:
Manchester Metropolitan University
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this pre-post design clinical trial is to develop a digital, theory-based Pursed Lip Breathing intervention protocol software system installed on smartphones (DT-PLB) and to preliminarily ...
Eligibility Criteria
Inclusion
- Diagnosed with COPD satisfying GOLD criteria (Agusti, 2022) ;
- Being Chinese;
- Able to understand, speak, and hear;
- Clinically stable for at least three months prior to enrollment (Soler-Cataluna et al., 2018) ;
- The classification of GOLD grades for patients is mild, moderate, and severe, which means: FEV1/FVC\<70%, FEV1\>30%pre (Agusti, 2022) ;
- Participants who were mindful about the IT technology and known how to use a smartphone.
Exclusion
- Impaired hand function causing inability to use the application;
- Have disorders in pleural effusion, pulmonary malignancy, heart diseases, stroke with sequels;
- Patients who have oral or nasal diseases cannot complete the exercise.
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 20 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06063733
Start Date
October 30 2023
End Date
April 20 2024
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China, 646000